Sign In
Buy RETA
$172.36
+0 (+0%)
At Close: Dec 22, 2023
Why Reata Pharmaceuticals Stock Is Soaring Today
04:33pm, Tuesday, 08'th Nov 2022 The Motley Fool
Investors are cheering the company's third-quarter update.
Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Lags Revenue Estimates
12:55pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue surprises of 8.09% and 62.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for th
Why Reata Pharmaceuticals Stock Is Soaring Today
11:33am, Tuesday, 08'th Nov 2022
Investors are cheering the company's third-quarter update.
Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Lags Revenue Estimates
09:02am, Tuesday, 08'th Nov 2022
Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue surprises of 8.09% and 62.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for th
Intercept Pharmaceuticals (ICPT) Reports Q3 Loss, Tops Revenue Estimates
12:15pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Intercept (ICPT) delivered earnings and revenue surprises of -159.49% and 2.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
PLANO, Texas--(BUSINESS WIRE)--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announce
2 On-Fire Biotech Stocks That Are Crushing the Bear Market
01:30pm, Monday, 31'st Oct 2022 The Motley Fool
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
2 On-Fire Biotech Stocks That Are Crushing the Bear Market
09:30am, Monday, 31'st Oct 2022
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
02:02pm, Wednesday, 19'th Oct 2022 Benzinga
Upgrades
According to Raymond James, the prior rating for Fortis Inc (NYSE:FTS) was changed from Market Perform to Outperform. In the second quarter, Fortis showed an EPS of $0.45, compared to $0.45 f
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
09:27am, Tuesday, 18'th Oct 2022 Benzinga
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case
Reata (RETA) Up After FDA Scraps AdCom Meeting for NDA Filing
04:52pm, Monday, 17'th Oct 2022 Zacks Investment Research
The FDA decides not to hold an advisory committee meeting for Reata Pharmaceuticals' (RETA) regulatory filing seeking approval for omaveloxolone in Friedreich's Ataxia.
Reata (RETA) Up After FDA Scraps AdCom Meeting for NDA Filing
03:03pm, Monday, 17'th Oct 2022
The FDA decides not to hold an advisory committee meeting for Reata Pharmaceuticals' (RETA) regulatory filing seeking approval for omaveloxolone in Friedreich's Ataxia.
Reata Pharmaceuticals, Inc. (RETA) Stock Jumps 20.6%: Will It Continue to Soar?
12:05pm, Monday, 17'th Oct 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further s
Reata Pharmaceuticals, Inc. (RETA) Stock Jumps 20.6%: Will It Continue to Soar?
09:47am, Monday, 17'th Oct 2022
Reata Pharmaceuticals, Inc. (RETA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further s
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
09:21am, Monday, 17'th Oct 2022 Benzinga
Gainers
Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45.
FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.
IMARA Inc. (NASDAQ: IMRA) shares climbed 46.9% to close
